Member Info for Magoo247

Applicable At Applicable For Data Item Value Generated Time Quality Indicator
04/05/2023 09:45:00 02/05/2023 System Entry Calorific Value, Saltfleetby , D+2 41.1600 04/05/2023 10:00:00
04/05/2023 09:45:00 02/05/2023 System Entry Energy, Saltfleetby , D+2 1977778.0000 04/05/2023 10:00:00
04/05/2023 09:45:00 02/05/2023 System Entry Volume, Saltfleetby , D+2 0.1728 04/05/2023 10:00:00

Why do people on here blame others for them pressing a button to buy - grow up and grow some ball FFS

Well Tuesday will tell, you’re either in or out - I’m in - Gla

strong fear of missing out now - this may hit 1.6 by end of business - gas gas gas

Looks to me Barney knows how many days are left in April - You back to school in the morning ?

yes but check this out System Entry Calorific Value, Saltfleetby, D+1 41.4000

I'll re-iterate not all deals are RSN'd - I like the steady rise (more sustainable) CF despite all his ramping over the years never wanted boom as this would inevitably rebound in the share price reduction but a Steady rise is what he wanted and me too - long may it continue !

Mr008 - Why to you continue to talk complete nonsense - you are one irritating scum bag, I bet you're one of those trolls who get off on frightening little boys and girls on snapchat - what pleasure do you get typing on here annoying the true investor - I guess when you're not on here you're running around a kids play ground with a clown mask on - did you wet your bed as a kid or get bullied in the playground - get out of here ?

Just you Rick - they don't RNS every, deal only when it's a wopper !

In this cost of living crisis thing that are expensive are getting cheaper and things that are cheap are getting more expensive - Angs is cheap - in my view this will change in the next 24/36 hours !

we all wait for the RNS - and some people don't read them - WTF - temp now - permanent summer - the temp can still get the gas to the grid !!!!!!!!!! which is £££££

What are you talking about ? Havegun - it only floated late last year - and most who invested prior on the original delisting are significanlty down ! I would suggest 0.5 on the harvest RNS

Those who have complained mostly yesterday - just because your expectations haven't been met in your timescales, it doesn't mean a thing ! successful investors, are patient and don't blame the company they invest in for their investment, it's your decision - Angus didn't frog march you to your broker with a gun to your head to say buy me / invest here ! You decided , so have the confidence and the conviction to either get out or shut up and support this business ! Company Gas flow will increase and so will the share price !

Angus Energy (ANGS LN) 1.69p, Market Cap £61m: Production update

Angus announced current production rates of 4-5mmcf/d from the SF7v sidetrack development well at the Saltfleetby gas field (100% WI), onshore UK.
The Company expects the well to clean up further, which is likely to raise that flow rate in the future, and will move to construct a new well flowline to enable full plateau production this summer.
The shares are down by 7% in early trading, reflecting test results from the SF7V sidetrack well that are in line with expectations and no more. The CPR had estimated a P90 target of ~10mmcf/d for the plateau rate of flow from all three wells, with the new well expected to nearly double volumes from the Saltfleetby field after clean-up. Following a transformational 2022 for the Company, additional development operations have been funded by a junior debt facility to limit dilution and management remains on-track to deliver sales gas volume growth in 2023.

if this goes to 20p Ria - I'll eat my wellies !

Lol - my post was a joke - I’ve had a Rolex for more 30 years - don’t wear it much - for that reason - although I live in a sleepy village in Scotland not a big city

Anyone got flow rates for yesterday - I’m out shopping is it a timex or a Rolex ?

Patience is all that's required !

Seems I was asleep on the 3rd - Feeling stupid !

hVIVO – a company focused on testing global infectious and respiratory disease products through clinical trials – has recorded positive interim results from its study involving Cidara Therapeutics’ CD388 influenza therapy.